Skip to main content
Premium Trial:

Request an Annual Quote

NCCN Including Use of VeriStrat in NSCLC Guidelines

NEW YORK (GenomeWeb) – The National Comprehensive Cancer Network has approved inclusion of Biodesix's VeriStrat proteomics test in its guidelines for non-small cell lung cancer, the Boulder, Colo.-based firm said today.

The updated guidelines recommend use of the test to help determine whether NSCLC patients entering the second line of treatment should receive Genentech's Tarceva (erlotinib), a targeted therapy which has fewer side effects and offers greater convenience compared to other standard chemotherapies. The NCCN guideline recommends VeriStrat for NSCLC patients with wild-type EGFR or with unknown EGFR status.

Biodesix noted that the guidelines state that "a patient with 'poor' classification should not be offered erlotinib in the second-line setting."

While erlotinib is often used in NSCLC patients with an EFGR mutation, such a mutation is seen in only a small percentage of patients, Biodesix said. VeriStrat helps clinicians identify those who may benefit from a targeted therapy.

"The goal, from a diagnostic perspective, is to identify patients who differentially respond to available therapies in this devastating disease," Biodesix CMO Richard Hockett said in a statement. "The ability of VeriStrat to provide prognostic and therapeutic guidance to improve patient outcomes is gaining wider recognition as standard of care by inclusion in NCCN guidelines."

The NCCN's decision follows last month's decision by Blue Cross Blue Shield affiliate Highmark to cover VeriStrat.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.